Cargando…

Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study

Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemaignen, Adrien, Ghout, Idir, Dinh, Aurélien, Gras, Guillaume, Fantin, Bruno, Zarrouk, Virginie, Carlier, Robert, Loret, Jean-Edouard, Denes, Eric, Greder, Alix, Lescure, François-Xavier, Boutoille, David, Tattevin, Pierre, Issartel, Bertrand, Cottier, Jean-Philippe, Bernard, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457841/
https://www.ncbi.nlm.nih.gov/pubmed/28538361
http://dx.doi.org/10.1097/MD.0000000000006387
_version_ 1783241620542455808
author Lemaignen, Adrien
Ghout, Idir
Dinh, Aurélien
Gras, Guillaume
Fantin, Bruno
Zarrouk, Virginie
Carlier, Robert
Loret, Jean-Edouard
Denes, Eric
Greder, Alix
Lescure, François-Xavier
Boutoille, David
Tattevin, Pierre
Issartel, Bertrand
Cottier, Jean-Philippe
Bernard, Louis
author_facet Lemaignen, Adrien
Ghout, Idir
Dinh, Aurélien
Gras, Guillaume
Fantin, Bruno
Zarrouk, Virginie
Carlier, Robert
Loret, Jean-Edouard
Denes, Eric
Greder, Alix
Lescure, François-Xavier
Boutoille, David
Tattevin, Pierre
Issartel, Bertrand
Cottier, Jean-Philippe
Bernard, Louis
author_sort Lemaignen, Adrien
collection PubMed
description Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolled in a prospective randomized antibiotic duration study, and patients with PVO-associated SND managed in 8 French referral centers. Risk factors for SND were determined by logistic regression. Ninety-seven patients with PVO-associated SND cases, and 297 controls were included. Risk factors for SND were epidural abscess [adjusted odds ratio, aOR 8.9 (3.8–21)], cervical [aOR 8.2 (2.8–24)], and/or thoracic involvement [aOR 14.8 (5.6–39)], Staphylococcus aureus PVO [aOR 2.5 (1.1–5.3)], and C-reactive protein (CRP) >150 mg/L [aOR 4.1 (1.9–9)]. Among the 81 patients with PVO-associated SND who were evaluated at 3 months, 62% had a favorable outcome, defined as a modified Rankin score ≤ 3. No factor was found significantly associated with good outcome, whereas high Charlson index [adjusted Hazard Ratio (aHR) 0.3 (0.1–0.9)], low American Spinal Injury Association (ASIA) impairment scale at diagnosis [aHR 0.4 (0.2–0.9)], and thoracic spinal cord compression [aHR 0.2 (0.08–0.5)] were associated with poor outcome. Duration of antibiotic treatment was not associated with functional outcome. SND is more common in cervical, thoracic, and S. aureus PVO, in the presence of epidural abscess, and when CRP >150 mg/L. Although neurological deterioration occurs in 30% of patients in early follow-up, the functional outcome is quite favorable in most cases after 3 months. The precise impact of optimal surgery and/or corticosteroids therapy must be specified by further studies.
format Online
Article
Text
id pubmed-5457841
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-54578412017-06-09 Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study Lemaignen, Adrien Ghout, Idir Dinh, Aurélien Gras, Guillaume Fantin, Bruno Zarrouk, Virginie Carlier, Robert Loret, Jean-Edouard Denes, Eric Greder, Alix Lescure, François-Xavier Boutoille, David Tattevin, Pierre Issartel, Bertrand Cottier, Jean-Philippe Bernard, Louis Medicine (Baltimore) 4900 Severe neurological deficit (SND) is a rare but major complication of pyogenic vertebral osteomyelitis (PVO). We aimed to determine the risk factors and the variables associated with clinical improvement for SND during PVO. This case–control study included patients without PVO-associated SND enrolled in a prospective randomized antibiotic duration study, and patients with PVO-associated SND managed in 8 French referral centers. Risk factors for SND were determined by logistic regression. Ninety-seven patients with PVO-associated SND cases, and 297 controls were included. Risk factors for SND were epidural abscess [adjusted odds ratio, aOR 8.9 (3.8–21)], cervical [aOR 8.2 (2.8–24)], and/or thoracic involvement [aOR 14.8 (5.6–39)], Staphylococcus aureus PVO [aOR 2.5 (1.1–5.3)], and C-reactive protein (CRP) >150 mg/L [aOR 4.1 (1.9–9)]. Among the 81 patients with PVO-associated SND who were evaluated at 3 months, 62% had a favorable outcome, defined as a modified Rankin score ≤ 3. No factor was found significantly associated with good outcome, whereas high Charlson index [adjusted Hazard Ratio (aHR) 0.3 (0.1–0.9)], low American Spinal Injury Association (ASIA) impairment scale at diagnosis [aHR 0.4 (0.2–0.9)], and thoracic spinal cord compression [aHR 0.2 (0.08–0.5)] were associated with poor outcome. Duration of antibiotic treatment was not associated with functional outcome. SND is more common in cervical, thoracic, and S. aureus PVO, in the presence of epidural abscess, and when CRP >150 mg/L. Although neurological deterioration occurs in 30% of patients in early follow-up, the functional outcome is quite favorable in most cases after 3 months. The precise impact of optimal surgery and/or corticosteroids therapy must be specified by further studies. Wolters Kluwer Health 2017-05-26 /pmc/articles/PMC5457841/ /pubmed/28538361 http://dx.doi.org/10.1097/MD.0000000000006387 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4900
Lemaignen, Adrien
Ghout, Idir
Dinh, Aurélien
Gras, Guillaume
Fantin, Bruno
Zarrouk, Virginie
Carlier, Robert
Loret, Jean-Edouard
Denes, Eric
Greder, Alix
Lescure, François-Xavier
Boutoille, David
Tattevin, Pierre
Issartel, Bertrand
Cottier, Jean-Philippe
Bernard, Louis
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title_full Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title_fullStr Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title_full_unstemmed Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title_short Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case–control study
title_sort characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: a case–control study
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457841/
https://www.ncbi.nlm.nih.gov/pubmed/28538361
http://dx.doi.org/10.1097/MD.0000000000006387
work_keys_str_mv AT lemaignenadrien characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT ghoutidir characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT dinhaurelien characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT grasguillaume characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT fantinbruno characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT zarroukvirginie characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT carlierrobert characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT loretjeanedouard characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT deneseric characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT grederalix characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT lescurefrancoisxavier characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT boutoilledavid characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT tattevinpierre characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT issartelbertrand characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT cottierjeanphilippe characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy
AT bernardlouis characteristicsofandriskfactorsforsevereneurologicaldeficitinpatientswithpyogenicvertebralosteomyelitisacasecontrolstudy